Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | BW | Hongjian Jin | ||||||
GSE241645 |
PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors [RNA-seq]
|
3 | Hongjian Jin | Sep 30, 2023 | ||||
GSE207012 |
CUT&Tag of KDM4A, B and C in BE2C cells
|
6 |
|
Hongjian Jin | Mar 04, 2024 | |||
GSE164454 |
KDM4 inhibition disrupts the core regulatory transcriptional circuitry in MYCN-driven neuroblastoma [Cut&Tag]
|
8 | Hongjian Jin | Mar 04, 2024 | ||||
GSE198752 |
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma [ChIP-Seq, 2]
|
8 |
|
Hongjian Jin | Sep 06, 2022 | |||
GSE198754 |
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma [CUT&Tag]
|
10 |
|
Hongjian Jin | Sep 06, 2022 | |||
GSE151493 |
Identification of 17-DMAG as a novel KDM4B inhibitor for combination therapy [ChIP-seq]
|
12 | Hongjian Jin | Dec 22, 2020 | ||||
GSE218265 |
PAX3-FOXO1 expression in endothelial progenitors dictates myogenic reprogramming and rhabdomyosarcoma identity[Cut&Run]
|
15 |
|
Hongjian Jin | Sep 30, 2023 | |||
GSE157093 |
Targeting KDM4B to disrupt the core regulatory transcription network governed by PAX3-FOXO1 in high-risk rhabdomyosarcoma [CUT&RUN]
|
18 | Hongjian Jin | Sep 06, 2022 | ||||
GSE198753 |
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma [CUT&RUN, 2]
|
18 |
|
Hongjian Jin | Sep 06, 2022 | |||
GSE164451 |
KDM4 inhibition disrupts the core regulatory transcriptional circuitry in MYCN-driven neuroblastoma [ChIP-seq]
|
20 | Hongjian Jin | Mar 04, 2024 | ||||
GSE151598 |
Identification of 17-DMAG as a novel KDM4B inhibitor for combination therapy
|
21 |
|
Hongjian Jin | Dec 22, 2020 | |||
GSE157094 |
Targeting KDM4B to disrupt the core regulatory transcription network governed by PAX3-FOXO1 in high-risk rhabdomyosarcoma [ChIP-seq]
|
28 | Hongjian Jin | Sep 06, 2022 | ||||
GSE207035 |
KDM4 histone lysine demethylases maintain the adrenergic core regulatory circuitry programed by MYCN in neuroblastoma
|
30 |
|
Hongjian Jin | Mar 02, 2024 | |||
GSE108344 |
Spontaneous DIPG Modeling Reveals Novel H3.3 K27M-Mediated Oncogenic Mechanisms Acting Through Epigenetic Effects [ChIP-seq]
|
59 | Hongjian Jin | Jan 03, 2019 | ||||
GSE164456 |
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma
|
69 |
|
Hongjian Jin | Mar 02, 2024 | |||
GSE218274 |
PAX3-FOXO1 expression in endothelial progenitors dictates myogenic reprogramming and rhabdomyosarcoma identity
|
75 | Hongjian Jin | Sep 29, 2023 | ||||
GSE115872 |
H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo [ChIP-Seq]
|
80 | Hongjian Jin | Mar 18, 2019 | ||||
GSE108364 |
Spontaneous DIPG Modeling Reveals Novel H3.3 K27M-Mediated Oncogenic Mechanisms Acting Through Epigenetic Effects
|
100 |
|
Hongjian Jin | Jan 03, 2019 | |||
GSE157095 |
Targeting KDM4B to disrupt the core regulatory transcription network governed by PAX3-FOXO1 in high-risk rhabdomyosarcoma
|
104 |
|
Hongjian Jin | Sep 06, 2022 | |||
GSE115875 |
H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo
|
130 |
|
Hongjian Jin | Mar 18, 2019 |